Crossref
Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer
The Internet Journal of Oncology · 2006
DOI: 10.5580/1752 ↗At a glance
Journal article in The Internet Journal of Oncology, 2006.
Abstract (original language)
This case report concerns an elderly patient with liver and bone metastases of breast cancer successfully treated for two-years with capecitabine as first line chemotherapy without any side effect.
Cite
APA
(2006). Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer. The Internet Journal of Oncology. https://doi.org/10.5580/1752
Vancouver
Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer. The Internet Journal of Oncology. 2006. doi:10.5580/1752
BibTeX
@article{euvimed2006,
title = {Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer},
journal = {The Internet Journal of Oncology},
year = {2006},
doi = {10.5580/1752}
}
EUVIMED